Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neo-adjuvant therapy in breast cancer.

× No keyword cloud information.

6 in total

1. Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer.

Authors: Jason R Brown; Michael P DiGiovanna; Brigid Killelea; Donald R Lannin; David L Rimm
Journal: Lab Invest Date: 2013-11-04 Impact factor: 5.662

2. Glutathione S-transferase M1 and T1 polymorphism and response to neoadjuvant chemotherapy (CAF) in breast cancer patients.

Authors: Anjali Mishra; Richa Chandra; Prateek Kumar Mehrotra; Prachi Bajpai; Deepa Agrawal
Journal: Surg Today Date: 2011-03-23 Impact factor: 2.549

3. Preclinical development of a neutral, estrogen receptor-targeted, tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers.

Authors: Tapan K Nayak; Helen J Hathaway; Chinnasamy Ramesh; Jeffrey B Arterburn; Donghai Dai; Larry A Sklar; Jeffrey P Norenberg; Eric R Prossnitz
Journal: J Nucl Med Date: 2008-05-15 Impact factor: 10.057

4. Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.

Authors: Jacques Medioni; Cyrille Huchon; Marie-Aude Le Frere-Belda; Henri Hofmann; Anne-Sophie Bats; Denise Eme; Jean-Marie Andrieu; Stéphane Oudard; Fabrice Lecuru; Eric Levy
Journal: Drugs R D Date: 2011

5. "Short Course" of Nonpegylated Liposomal Doxorubicin Plus Paclitaxel and Trastuzumb as Primary Systemic Therapy for Operable and Locally-Advanced Breast Cancer: A Phase II Study (PacLiDox 07).

Authors: D Rossi; B Pistilli; D Morale; V Casadei; G Benedetti; P Alessandroni; V Catalano; P Giordani; F Graziano; S Luzi Fedeli; G Fiorentini
Journal: World J Oncol Date: 2011-10-28

6. TMB and TCR Are Correlated Indicators Predictive of the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer.

Authors: Hongling Liang; Jia Huang; Xiang Ao; Weibang Guo; Yu Chen; Danxia Lu; Zhiyi Lv; Xiaojun Tan; Weixing He; Ming Jiang; Haoming Xia; Yongtao Zhan; Weiling Guo; Zhiqing Ye; Lei Jiao; Jie Ma; Changxi Wang; Hongsheng Li; Xuchao Zhang; Jianqing Huang
Journal: Front Oncol Date: 2021-12-07 Impact factor: 6.244

6 in total